The Department of Defense is praising FDA's approval of BioPort's new manufacturing facility to produce anthrax vaccine. DOD expects an announcement regarding its anthrax vaccination policy in the near future.


Using funds from legislation signed into law Jan. 10, HHS announces it will provide states with $1.1 billion for bioterrorism-related efforts.





Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.